QA108
/ MingMed Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 23, 2025
QA108 Phase III Study in Subjects With Intermediate AMD
(clinicaltrials.gov)
- P3 | N=400 | Recruiting | Sponsor: Smilebiotek Zhuhai Limited
New P3 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
July 15, 2024
QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration
(clinicaltrials.gov)
- P2 | N=120 | Completed | Sponsor: Smilebiotek Zhuhai Limited | Recruiting ➔ Completed
Trial completion • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
1 to 2
Of
2
Go to page
1